Vaprisol

Active Ingredient(s): Conivaptan Hydrochloride
FDA Approved: * December 29, 2005
Pharm Company: * ASTELLAS
Category: Diuretic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vaprisol Overview

Conivaptan (YM 087, brand name Vaprisol) is a non-peptide inhibitor of the receptor for anti-diuretic hormone, also called vasopressin. It was approved in 2004 for hyponatremia (low blood sodium levels). The compound was discovered by Astellas and marked in 2006. The drug is now marketed by Cumberland Pharmaceuticals, Inc. Conivaptan inhibits two of the three subtypes of the vasopressin receptor (V1a and V2). Effectively, it causes iatrogenic nephrogenic diabetes insipidus. Conivaptan has no...

Read more Vaprisol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Conivaptan

Recent Vaprisol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Conivaptan Hydrochloride
  • Injection: 20mg, 20mg/100ml (0.2mg/ml), 20mg/100ml(0.2mg/ml), 20mg/4ml (5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vaprisol: (1 result)

Sorted by National Drug Code
  • 0469-1602 Vaprisol 20 mg/100ml Intravenous Solution by Astellas Pharma Us, Inc.

Other drugs which contain Conivaptan Hydrochloride or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA